Literature DB >> 27713882

Current epidemiology of sepsis in mainland China.

Xuelian Liao1, Bin Du2, Meizhu Lu1, Minming Wu1, Yan Kang1.   

Abstract

The disease burden of sepsis is a global issue. Most of the large-scale epidemiological investigations on sepsis have been carried out in developed countries. The population of 1.3 billion in mainland China accounts for approximately 1/5th of the whole world population. Thus, the knowledge of the incidence and mortality of sepsis in mainland China is vital before employing measures for its improvement. However, most of the epidemiological data of sepsis in mainland China was obtained from ICU settings, and thus lacks the population-based incidence and mortality of sepsis. In the present review, we summarized the limited literature encompassing the incidence, mortality, long-term outcome, and pathogens of sepsis in mainland China. Therefore, it might provide some valuable information regarding the sepsis disease burden and current issues in the management of sepsis in mainland China.

Entities:  

Keywords:  Sepsis; epidemiology; incidence; mortality

Year:  2016        PMID: 27713882      PMCID: PMC5050198          DOI: 10.21037/atm.2016.08.51

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  31 in total

1.  Differences in Impact of Definitional Elements on Mortality Precludes International Comparisons of Sepsis Epidemiology-A Cohort Study Illustrating the Need for Standardized Reporting.

Authors:  Manu Shankar-Hari; David A Harrison; Kathryn M Rowan
Journal:  Crit Care Med       Date:  2016-12       Impact factor: 7.598

2.  Implementing surviving sepsis campaign bundles in China: a prospective cohort study.

Authors:  Zhi-Qiang Li; Xiu-Ming Xi; Xin Luo; Jie Li; Li Jiang
Journal:  Chin Med J (Engl)       Date:  2013       Impact factor: 2.628

3.  Sepsis and septic shock in low-income and middle-income countries: need for a different paradigm.

Authors:  Jordi Rello; Hakan Leblebicioglu
Journal:  Int J Infect Dis       Date:  2016-04-25       Impact factor: 3.623

4.  Structure, Organization, and Delivery of Critical Care in Asian ICUs.

Authors:  Yaseen M Arabi; Jason Phua; Younsuck Koh; Bin Du; Mohammad Omar Faruq; Masaji Nishimura; Wen-Feng Fang; Charles Gomersall; Hussain N Al Rahma; Hani Tamim; Hasan M Al-Dorzi; Fahad M Al-Hameed; Neill K J Adhikari; Musharaf Sadat
Journal:  Crit Care Med       Date:  2016-10       Impact factor: 7.598

5.  Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China.

Authors:  Baoli Cheng; Guohao Xie; ShangLong Yao; Xinmin Wu; Qulian Guo; Miaoning Gu; Qiang Fang; Qiuping Xu; Dongxin Wang; Yuhong Jin; ShiYing Yuan; Junlu Wang; Zhaohui Du; Yunbo Sun; XiangMing Fang
Journal:  Crit Care Med       Date:  2007-11       Impact factor: 7.598

Review 6.  Clinical review: critical care medicine in mainland China.

Authors:  Bin Du; Xiuming Xi; Dechang Chen; Jinmin Peng
Journal:  Crit Care       Date:  2010-02-25       Impact factor: 9.097

7.  Impaired long-term quality of life in survivors of severe sepsis : Chinese multicenter study over 6 years.

Authors:  K Zhang; X Mao; Q Fang; Y Jin; B Cheng; G Xie; H Li; L Yu; T Zhu; H Wang; X Liu; Y Zhang; Y Jin; N Zhang; T Lou; X M Fang
Journal:  Anaesthesist       Date:  2013-11-30       Impact factor: 1.041

8.  [The clinical analysis of 419 severe sepsis patients in intensive care unit].

Authors:  Jin Lin; Pei Liu; Haizhou Zhuang; Meili Duan; Ang Li
Journal:  Zhonghua Wei Zhong Bing Ji Jiu Yi Xue       Date:  2014-03

Review 9.  Short-term Gains with Long-term Consequences: The Evolving Story of Sepsis Survivorship.

Authors:  Jason H Maley; Mark E Mikkelsen
Journal:  Clin Chest Med       Date:  2016-03-10       Impact factor: 2.878

10.  The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study).

Authors:  Andrew Rhodes; Gary Phillips; Richard Beale; Maurizio Cecconi; Jean Daniel Chiche; Daniel De Backer; Jigeeshu Divatia; Bin Du; Laura Evans; Ricard Ferrer; Massimo Girardis; Despoina Koulenti; Flavia Machado; Steven Q Simpson; Cheng Cheng Tan; Xavier Wittebole; Mitchell Levy
Journal:  Intensive Care Med       Date:  2015-06-25       Impact factor: 17.440

View more
  16 in total

1.  Health economic evaluation of patients with sepsis after gastrointestinal tumor surgery-a cost consequences analysis in China.

Authors:  Ren-Xiong Chen; Zhou-Qiao Wu; Zi-Yu Li; Hong-Zhi Wang; Jia-Fu Ji
Journal:  J Gastrointest Oncol       Date:  2020-10

2.  Th17, rather than Th1 cell proportion, is closely correlated with elevated disease severity, higher inflammation level, and worse prognosis in sepsis patients.

Authors:  Yu Liu; Xiaopin Wang; Li Yu
Journal:  J Clin Lab Anal       Date:  2021-03-11       Impact factor: 2.352

3.  Epidemiology of sepsis in Brazil: Incidence, lethality, costs, and other indicators for Brazilian Unified Health System hospitalizations from 2006 to 2015.

Authors:  Ricardo Alfredo Quintano Neira; Silvio Hamacher; André Miguel Japiassú
Journal:  PLoS One       Date:  2018-04-13       Impact factor: 3.240

4.  Clinical significance and prognosis of serum tenascin-C in patients with sepsis.

Authors:  Weifang Yuan; Wei Zhang; Xiaofang Yang; Liyuan Zhou; Ziwei Hanghua; Kailiang Xu
Journal:  BMC Anesthesiol       Date:  2018-11-15       Impact factor: 2.217

5.  Downregulation of JKAP is correlated with elevated disease risk, advanced disease severity, higher inflammation, and poor survival in sepsis.

Authors:  Min Zhao; Xing Huang
Journal:  J Clin Lab Anal       Date:  2019-06-17       Impact factor: 2.352

6.  Circulating lncRNA ITSN1-2 is upregulated, and its high expression correlates with increased disease severity, elevated inflammation, and poor survival in sepsis patients.

Authors:  Qingwei Zeng; Jingdong Wu; Shijiang Yang
Journal:  J Clin Lab Anal       Date:  2019-02-25       Impact factor: 2.352

7.  MiR-125b but not miR-125a is upregulated and exhibits a trend to correlate with enhanced disease severity, inflammation, and increased mortality in sepsis patients.

Authors:  Xiaoping Zhu
Journal:  J Clin Lab Anal       Date:  2019-11-07       Impact factor: 2.352

8.  High sPLA2-IIA level is associated with eicosanoid metabolism in patients with bacterial sepsis syndrome.

Authors:  Nurul Saadah Ahmad; Toh Leong Tan; Khaizurin Tajul Arifin; Wan Zurinah Wan Ngah; Yasmin Anum Mohd Yusof
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

9.  Astaxanthin Protects Dendritic Cells from Lipopolysaccharide-Induced Immune Dysfunction.

Authors:  Yinyan Yin; Nuo Xu; Yi Shi; Bangyue Zhou; Dongrui Sun; Bixia Ma; Zhengzhong Xu; Jin Yang; Chunmei Li
Journal:  Mar Drugs       Date:  2021-06-17       Impact factor: 5.118

10.  Resveratrol protects against early polymicrobial sepsis-induced acute kidney injury through inhibiting endoplasmic reticulum stress-activated NF-κB pathway.

Authors:  Nian Wang; Li Mao; Liu Yang; Jiang Zou; Ke Liu; Meidong Liu; Huali Zhang; Xianzhong Xiao; Kangkai Wang
Journal:  Oncotarget       Date:  2017-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.